Nigeria’s pharmaceutical system is entering a defining moment. For decades, it has operated with fragmented coordination, limited manufacturing capacity, and heavy dependence on donor-driven delivery models. Today, these long-standing pressures have reached a critical point. The departure of global pharmaceutical companies, rising medicine prices and the approaching 2028 transition away from vaccine funding have created an environment where the system to confront realities ca

Medicines sit at the centre of almost every patient interaction across the NHS. Yet the systems designed to support their safe and effective use remain fragmented, unevenly digitised, and often disconnected from the realities of frontline care. While policy ambition around digital transformation has accelerated, the practical conditions needed to translate data into better medicines use have not always kept pace. These themes shaped the fifth roundtable in the UK Medicines Po

As the NHS undergoes profound technological, educational and workforce shifts, pharmacy must evolve alongside it. The fourth roundtable of the UK Medicines Policy Series, hosted by the Global Policy Network (GPN), examined this moment of transition through a unifying lens: innovation. Chair Reena Patel captured the purpose of the session clearly: “We will explore the future of the profession through that lens of innovation and explore how pharmacy can drive better outcomes th

The NHS is asking more of pharmacists than ever before, yet the systems designed to support them have not kept pace. As workforce pressures intensify across the health service, pharmacy at a critical juncture: highly trained, widely accessible, and increasingly essential, but still constrained by structural barriers. Today, that is evolving into a new strategic frontier, one that asks; " How do we develop and utilise the pharmacy workforce to meet growing system needs?". Thi